0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Substance Abuse/Alcoholism
 161-180 of 1209 Articles
JAMA Internal Medicine | 
Original Investigation |  FREE
Peter Nordström, PhD; Anna Nordström, PhD; Marie Eriksson, PhD; et al.
JAMA Intern Med. 2013;173(17):1612-1618. doi:10.1001/jamainternmed.2013.9079.
Includes: Supplemental Content

JAMA | 
Editorial | 
Patrick G. O’Connor, MD, MPH
JAMA. 2013;310(11):1132-1134. doi:10.1001/jama.2013.277610.

JAMA | 
Original Investigation |  FREE
Richard Saitz, MD, MPH; Debbie M. Cheng, ScD; Michael Winter, MPH; et al.
JAMA. 2013;310(11):1156-1167. doi:10.1001/jama.2013.277609.
Includes: Supplemental Content

JAMA | 
Global Health | 
M. J. Friedrich
JAMA. 2013;310(11):1113. doi:10.1001/jama.2013.278239.

JAMA | 
Editorial | 
Dina L. Halegoua-De Marzio, MD; Jonathan M. Fenkel, MD
JAMA. 2013;310(10):1029-1030. doi:10.1001/jama.2013.276301.

JAMA | 
Original Investigation |  FREE
Philippe Mathurin, MD; Alexandre Louvet, MD; Alain Duhamel, PhD; et al.
JAMA. 2013;310(10):1033-1041. doi:10.1001/jama.2013.276300.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Original Investigation |  FREE
Casey Crump, MD, PhD; Kristina Sundquist, MD, PhD; Marilyn A. Winkleby, PhD; et al.
JAMA Psychiatry. 2013;70(9):931-939. doi:10.1001/jamapsychiatry.2013.1394.
Includes: Supplemental Content

JAMA Psychiatry | 
Editorial | 
Theodore A. Slotkin, PhD
JAMA Psychiatry. 2013;70(9):901-902. doi:10.1001/jamapsychiatry.2013.1951.

JAMA Psychiatry | 
Original Investigation |  FREE
Darya Gaysina, PhD; David M. Fergusson, PhD; Leslie D. Leve, PhD; et al.
JAMA Psychiatry. 2013;70(9):956-963. doi:10.1001/jamapsychiatry.2013.127.
Includes: Supplemental Content

JAMA Psychiatry | 
Viewpoint | 
Robyn M. Brown, PhD; Yonatan M. Kupchik, PhD; Peter W. Kalivas, PhD
JAMA Psychiatry. 2013;70(9):895-897. doi:10.1001/jamapsychiatry.2013.2207.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(8):789. doi:10.1001/jama.2013.194488.

JAMA | 
From JAMA's Daily News Site | 
JAMA. 2013;310(7):681. doi:10.1001/jama.2013.194337.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(7):684. doi:10.1001/jama.2013.135469.

JAMA | 
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(6):570-571. doi:10.1001/jama.2013.117024.

JAMA | 
Original Investigation |  FREE
US Burden of Disease Collaborators
JAMA. 2013;310(6):591-606. doi:10.1001/jama.2013.13805.
Includes: Supplemental Content

JAMA | 
Editorial | 
Katherine Mills, PhD
JAMA. 2013;310(5):482-483. doi:10.1001/jama.2013.8269.

JAMA | 
Editorial | 
Charles C. Engel, MD, MPH
JAMA. 2013;310(5):484-485. doi:10.1001/jama.2013.92420.

JAMA | 
Editorial | 
Thomas B. Cole, MD, MPH; Annette Flanagin, RN, MA
JAMA. 2013;310(5):486-487. doi:10.1001/jama.2013.218058.

JAMA | 
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(5):468-469. doi:10.1001/jama.2013.75770.

JAMA | 
Original Investigation |  FREE
Edna B. Foa , PhD; David A. Yusko, PsyD; Carmen P. McLean, PhD; et al.
JAMA. 2013;310(5):488-495. doi:10.1001/jama.2013.8268.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Clinical Trials Update  | 
Genotype Doesn’t Affect Response to Naltrexone for Alcohol Dependence
Anita Slomski, MA
JAMA
Viewpoint  | 
Ideological Anachronism Involving Needle and Syringe Exchange Programs:  Lessons From the Indiana HIV Outbreak
Josiah D. Rich, MD, MPH; Eli Y. Adashi, MD, MS
JAMA
News From the Food and Drug Administration  | 
Final Guidance Issued on Abuse-Deterrent Opioids
Rita Rubin, MA
JAMA Psychiatry
Original Investigation  | 
Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States:  Lessons Learned From OxyContin
Theodore J. Cicero, PhD; Matthew S. Ellis, MPE